Apellis Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Apellis Pharmaceuticals Inc 's inventory turnover ratio, the ratio that measures Apellis Pharmaceuticals Inc 's ability to manage its supply chain, sequentially decreased to 0.15 in the first quarter 2026, but it does not raise any concerns as Apellis Pharmaceuticals Inc continue to execute well, and the inventory turnover ratio remains above the average. Apellis Pharmaceuticals Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 2433 days, from 1825 days, in the Dec 31 2025 quarter.

Within Healthcare sector 371 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1949, from total ranking in the fourth quarter 2025 at 2107.

APLS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Apellis Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

APLS Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	59.34 %	75.12 %	1.45 %	-20.8 %	-48.87 %
Y / Y Cost of Sales Growth	-14.53 %	-	-	-	196.2 %
Inventory Turnover Ratio (TTM)	0.15	-	-	-	0.21
APLS's Total Ranking	# 1949	# 2107	# 2026	# 2037	# 2047
Average inventory processing period	2362	-	-	-	1707
Seq. Inventory Growth	-7.82 %	16.07 %	1.5 %	46.72 %	1.31 %
Seq. Cost of Sales Growth	-	-	-	-	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 118
Healthcare Sector	# 372
Overall Market	# 1949

Inventory Turnover Ratio Statistics
High	Average	Low
0.23	0.14	0.05
(Jun 30 2025)		(Sep 30 2024)

APLS Company Profile >> Back to APLS Efficiency Comparisons >> Compare APLS Inventory Turnover Ratio to its Competitors

Financial Statements
Apellis Pharmaceuticals Inc 's Inventories	$ 131 Millions	Visit APLS's Balance sheet
Apellis Pharmaceuticals Inc 's Cost of Revenues TTM	$ 20 Millions	Visit APLS's Income Statement
What are APLS's Sales?		Visit APLS's Sales by Segment

Other Inventory Turnover Ratios
Apellis Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
APLS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for APLS's Competitors
Inventory Turnover Ratio for APLS's Suppliers
Inventory Turnover Ratio for APLS's Customers

You may also want to know
APLS's Sales Growth Rates	APLS's Pe Price to earnings ratio	APLS's Receivables Turnover Ratio	APLS's Stock Quote
APLS's Net Income Growth Rates	APLS's Ps Price to Sales ratio	APLS's Sales per Employee	APLS's Asset Turnover Ratio
APLS's Net Margin	APLS's Pb Price to Book ratio	APLS's Financial Strength Ratios	APLS's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
X4 Pharmaceuticals Inc	0.40	$ 1.639 Millions	$ 4 Millions
Clene Inc	0.40	$ 0.023 Millions	$ 0 Millions
Outlook Therapeutics Inc	0.40	$ 1.408 Millions	$ 4 Millions
Co diagnostics Inc	0.40	$ 0.399 Millions	$ 1 Millions
Regeneron Pharmaceuticals Inc	0.39	$ 1,248.700 Millions	$ 3,191 Millions
Soleno Therapeutics Inc	0.38	$ 3.898 Millions	$ 10 Millions
Guided Therapeutics Inc	0.37	$ 0.196 Millions	$ 1 Millions
Alpha Cognition Inc.	0.31	$ 1.300 Millions	$ 4 Millions
Aditxt Inc	0.31	$ 0.012 Millions	$ 0 Millions
Nexalin Technology Inc	0.31	$ 0.050 Millions	$ 0 Millions
EBR Systems, Inc.	0.30	$ 3.305 Millions	$ 11 Millions
Vystar Corporation	0.27	$ 0.017 Millions	$ 0 Millions
Immunitybio inc	0.25	$ 0.933 Millions	$ 4 Millions
Adagio Medical Holdings inc	0.23	$ 0.431 Millions	$ 2 Millions
Agios Pharmaceuticals Inc	0.20	$ 6.579 Millions	$ 33 Millions
Biocorrx Inc	0.17	$ 0.025 Millions	$ 0 Millions
Bioadaptives Inc	0.17	$ 0.007 Millions	$ 0 Millions
Femasys Inc	0.16	$ 0.914 Millions	$ 6 Millions
Apellis Pharmaceuticals Inc	0.15	$ 20.000 Millions	$ 129 Millions
Yubo International Biotech Limited	0.14	$ 0.004 Millions	$ 0 Millions
Citius Pharmaceuticals Inc	0.05	$ 1.118 Millions	$ 21 Millions
Ptc Therapeutics inc	0.05	$ 3.100 Millions	$ 60 Millions
Invo Fertility Inc	0.04	$ 0.008 Millions	$ 0 Millions

Date modified: 2026-08-30T14:57:51+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.